Sanofi (SNY) Interest & Investment Income (2009 - 2026)

Sanofi has disclosed Interest & Investment Income across 18 years of filings, most recently posting $89.5 million for Q2 2026.

• In Q2 2026, Interest & Investment Income fell 19.32% year-over-year to $89.5 million; the TTM figure through Jun 2026 stood at $405.7 million (down 11.32% YoY), while the FY2025 annual figure was $458.6 million, down 18.35% from the prior year.
• Interest & Investment Income came in at $89.5 million for Q2 2026 at Sanofi, up from $70.2 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $348.4 million in Q3 2025 to a low of -$102.4 million in Q4 2025.
• Average Interest & Investment Income over 5 years is $111.4 million, with a median of $117.3 million recorded in 2022.
• Year-over-year, Interest & Investment Income jumped 2122.96% in 2022 and slumped 191.3% in 2025.
• Over 5 years, Interest & Investment Income stood at $122.4 million in 2022, then jumped by 36.22% to $166.8 million in 2023, then slumped by 32.72% to $112.2 million in 2024, then sank by 191.3% to -$102.4 million in 2025, then soared by 187.37% to $89.5 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $89.5 million in Q2 2026, $70.2 million in Q1 2026, and -$102.4 million in Q4 2025.